FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1991809265> ?p ?o ?g. }

• W1991809265 abstract "Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DCPrimary culture of cancer cells can be an excellent platform for investigating the biology of cancer and predicting chemosensitivity for individual patients, yet has been hampered by technical difficulties. We established a method of primary culture for human colorectal cancer: cancer tissue-originated spheroid (CTOS) method. The principle of the method is to maintain cell-cell contact throughout preparation and culture; never dissociating the samples into single cells. The clusters of cancer cells turn out to spheroids, CTOSs, within a short period. CTOSs of colorectal cancer consisted of highly purified cancer cells, and they were prepared with high efficiency. We applied the CTOS method to non-small cell lung cancer and urothelial cancer.For non-small cell lung cancer, we used 125 surgical specimens and 18 pleural effusions. The success rate of CTOS preparation from surgical specimens was 80.0%. CTOSs were subjected to sensitivity assay and pathway activation assay for the EGFR tyrosine kinase inhibitor (TKI) erlotinib. The sensitivity differed among individual patient CTOSs. The EGFR mutation status and expression levels corresponded with erlotinib sensitivity, confirming previous clinical findings. Next, we examined urothelial cancer. The success rate of CTOS preparation from the non muscle-invasive urothelial cancer was 90.7%, whereas that from the muscle-invasive urothelial cancer was 68.2%. Total development rate was 84.2%.Using these CTOSs, we investigated the effects of growth factors on the growth of CTOS in vitro. Among the growth factors examined, including EGF, IGF-1, basic FGF, and activin A, we found that heregulin (HRG)/neuregulin1, a ligand of HER3, potently induced CTOS growth in both lung and urothelial cancers. HRG promoted the growth of primary CTOSs in 10 out of 13 (71.4%) cases of lung cancer, and in 2 out of 4 (50%) cases of urothelial cancer. Along with the growth, HRG most potently stimulated the phosphorylation of AKT. In lung cancer CTOSs, a neutralizing antibody against HER3 inhibited the growth and the phosphorylation of HER3 and AKT.In all three tumor types examined, CTOSs formed xenograft tumors in immunodeficient mice, and the tumors retained the features of the parental tumors. As CTOS can be cryopreserved, we are accumulating stocks of CTOSs derived from patient samples as well as the CTOSs from xenograft tumors. CTOS experiments can be shuttled between in vitro and in vivo.Thus, the CTOS method enables us to obtain primary colorectal, lung, and urothelial tumor cells of high viability and purity. CTOS could be a new platform for studying lung cancer biology, and be useful to select patients for molecular targeting drugs.Citation Format: Masahiro Inoue, Hiroko Endo, Masayuki Ohue, Kazuo Nishimura, Fumio Imamura, Jiro Okami, Hiroaki Okuyama. Cancer tissue-derived spheroid, CTOS, for evaluation of drug response from individual patient tumor samples. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 3832. doi:10.1158/1538-7445.AM2013-3832" @default.
• W1991809265 created "2016-06-24" @default.
• W1991809265 creator A5016354646 @default.
• W1991809265 creator A5017579694 @default.
• W1991809265 creator A5047714811 @default.
• W1991809265 creator A5060407711 @default.
• W1991809265 creator A5061233614 @default.
• W1991809265 creator A5074620324 @default.
• W1991809265 creator A5077224975 @default.
• W1991809265 date "2013-04-15" @default.
• W1991809265 modified "2023-09-29" @default.
• W1991809265 title "Abstract 3832: Cancer tissue-derived spheroid, CTOS, for evaluation of drug response from individual patient tumor samples." @default.
• W1991809265 doi "https://doi.org/10.1158/1538-7445.am2013-3832" @default.
• W1991809265 hasPublicationYear "2013" @default.
• W1991809265 type Work @default.
• W1991809265 sameAs 1991809265 @default.
• W1991809265 citedByCount "1" @default.
• W1991809265 countsByYear W19918092652017 @default.
• W1991809265 crossrefType "proceedings-article" @default.
• W1991809265 hasAuthorship W1991809265A5016354646 @default.
• W1991809265 hasAuthorship W1991809265A5017579694 @default.
• W1991809265 hasAuthorship W1991809265A5047714811 @default.
• W1991809265 hasAuthorship W1991809265A5060407711 @default.
• W1991809265 hasAuthorship W1991809265A5061233614 @default.
• W1991809265 hasAuthorship W1991809265A5074620324 @default.
• W1991809265 hasAuthorship W1991809265A5077224975 @default.
• W1991809265 hasConcept C121608353 @default.
• W1991809265 hasConcept C126322002 @default.
• W1991809265 hasConcept C142724271 @default.
• W1991809265 hasConcept C143998085 @default.
• W1991809265 hasConcept C2776256026 @default.
• W1991809265 hasConcept C2778087573 @default.
• W1991809265 hasConcept C2779438470 @default.
• W1991809265 hasConcept C502942594 @default.
• W1991809265 hasConcept C526805850 @default.
• W1991809265 hasConcept C71924100 @default.
• W1991809265 hasConcept C96232424 @default.
• W1991809265 hasConceptScore W1991809265C121608353 @default.
• W1991809265 hasConceptScore W1991809265C126322002 @default.
• W1991809265 hasConceptScore W1991809265C142724271 @default.
• W1991809265 hasConceptScore W1991809265C143998085 @default.
• W1991809265 hasConceptScore W1991809265C2776256026 @default.
• W1991809265 hasConceptScore W1991809265C2778087573 @default.
• W1991809265 hasConceptScore W1991809265C2779438470 @default.
• W1991809265 hasConceptScore W1991809265C502942594 @default.
• W1991809265 hasConceptScore W1991809265C526805850 @default.
• W1991809265 hasConceptScore W1991809265C71924100 @default.
• W1991809265 hasConceptScore W1991809265C96232424 @default.
• W1991809265 hasLocation W19918092651 @default.
• W1991809265 hasOpenAccess W1991809265 @default.
• W1991809265 hasPrimaryLocation W19918092651 @default.
• W1991809265 hasRelatedWork W1582999690 @default.
• W1991809265 hasRelatedWork W1982890204 @default.
• W1991809265 hasRelatedWork W1983501060 @default.
• W1991809265 hasRelatedWork W1995302565 @default.
• W1991809265 hasRelatedWork W2010273242 @default.
• W1991809265 hasRelatedWork W2012258551 @default.
• W1991809265 hasRelatedWork W2121646539 @default.
• W1991809265 hasRelatedWork W2206889725 @default.
• W1991809265 hasRelatedWork W2266347788 @default.
• W1991809265 hasRelatedWork W2317269602 @default.
• W1991809265 hasRelatedWork W2331543161 @default.
• W1991809265 hasRelatedWork W2524386165 @default.
• W1991809265 hasRelatedWork W2563342254 @default.
• W1991809265 hasRelatedWork W2606225193 @default.
• W1991809265 hasRelatedWork W2801862162 @default.
• W1991809265 hasRelatedWork W2887636610 @default.
• W1991809265 hasRelatedWork W2967321037 @default.
• W1991809265 hasRelatedWork W2977930699 @default.
• W1991809265 hasRelatedWork W2980770048 @default.
• W1991809265 hasRelatedWork W3013593525 @default.
• W1991809265 isParatext "false" @default.
• W1991809265 isRetracted "false" @default.
• W1991809265 magId "1991809265" @default.
• W1991809265 workType "article" @default.